Detalhe da pesquisa
1.
Washout Periods in Inflammatory Bowel Disease Trials: A Systematic Literature Review and Proposed Solutions.
Clin Gastroenterol Hepatol
; 22(4): 896-898.e13, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37743039
2.
Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model.
Gut
; 72(1): 39-48, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361684
3.
Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study.
Clin Gastroenterol Hepatol
; 21(9): 2338-2346.e3, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987302
4.
Natural History of Anal Ulcerations in Pediatric-Onset Crohn's Disease: Long-Term Follow-Up of a Population-Based Study.
Am J Gastroenterol
; 118(9): 1671-1678, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104674
5.
New Therapeutic Strategies Are Associated With a Significant Decrease in Colectomy Rate in Pediatric Ulcerative Colitis.
Am J Gastroenterol
; 118(11): 1997-2004, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37141541
6.
New Therapeutic Strategies Have Changed the Natural History of Pediatric Crohn's Disease: A Two-Decade Population-Based Study.
Clin Gastroenterol Hepatol
; 20(11): 2588-2597.e1, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131345
7.
Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.
Dig Dis Sci
; 65(5): 1445-1452, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31599389
8.
Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn's Disease.
Dig Dis Sci
; 65(9): 2664-2674, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811438
9.
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy.
Clin Gastroenterol Hepatol
; 21(5): 1368-1371.e2, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944833
10.
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.
Clin Gastroenterol Hepatol
; 14(2): 242-50.e1-2, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26432476
11.
Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.
Dig Dis Sci
; 61(10): 2986-2992, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401274
12.
Histological healing induced by tofacitinib in ulcerative colitis: A multicentre study.
Dig Liver Dis
; 56(4): 613-621, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38065698
13.
Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study.
Dig Liver Dis
; 56(1): 21-28, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37137808
14.
Changes Over Time in the Lémann Index and the Inflammatory Bowel Disease Disability Index in a Prospective Cohort of Patients With Crohn's Disease.
Inflamm Bowel Dis
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597799
15.
[Crohn's disease or ulcerative colitis?] / Maladie de Crohn ou rectocolite hémorragique ?
Rev Prat
; 68(3): e119, 2018 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-30869310
16.
[Inflammatory bowel diseases in adults and children]. / Maladies inflammatoires chroniques de l'intestin (MICI) chez l'adulte et l'enfant.
Rev Prat
; 68(3): e109-e118, 2018 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-30869309
17.
Etrasimod for the treatment of ulcerative colitis.
Immunotherapy
; 15(5): 311-321, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789612
18.
Promising phase II biologics for future Crohn's disease therapy.
Expert Opin Investig Drugs
; 32(6): 495-507, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249522
19.
Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease.
United European Gastroenterol J
; 11(8): 797-806, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37670487
20.
A Comparison of Treatment Effect Sizes in Matched Phase 2 and Phase 3 Trials of Advanced Therapeutics in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
Clin Transl Gastroenterol
; 14(11): e00629, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37578211